Celularity (CELUW) Gross Profit (QoQ) (2020 - 2025)
Celularity (CELUW) Gross Profit (QoQ) (2020 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Celularity |
- |
- |
-3.27 Mn |
| Date | Value |
|---|
| Dec 31, 2025 |
-336.96% |
| Sep 30, 2025 |
179.35% |
| Jun 30, 2025 |
-93.72% |
| Mar 31, 2025 |
218.29% |
| Dec 31, 2024 |
-222.94% |
| Sep 30, 2024 |
-45.80% |
| Jun 30, 2024 |
-23.41% |
| Mar 31, 2024 |
421.01% |
| Dec 31, 2023 |
1,260.33% |
| Sep 30, 2023 |
-91.39% |
| Jun 30, 2023 |
10.56% |
| Mar 31, 2023 |
3,815.38% |
| Dec 31, 2022 |
-101.61% |
| Sep 30, 2022 |
-3.43% |
| Jun 30, 2022 |
0.60% |
| Mar 31, 2022 |
60.30% |
| Dec 31, 2021 |
-78.95% |
| Sep 30, 2021 |
275.93% |
| Jun 30, 2021 |
35.64% |
| Mar 31, 2021 |
81.10% |
